Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Here for the party: Mobile bar wants you to drink your brand (and its own laid-back, good-times vibe)
A new mobile bar business wants to take the cockiness out of the cocktail scene. “There’s a lot of ego in the cocktail scene, but we think the bar should be a distraction,” said Brian Shellenberger, co-founder of runner! cocktails. “When you’re having a stressed out week, what do you do? You go to a…
Look up for ‘King Me’: How Rif Raf Giraffe’s colorful new mural paints a full circle moment on this Crossroads corner
The chaos created by an unexpected building collapse that sent Jason Harrington’s East Crossroads apartment crumbling to the pavement below ultimately made room for an even larger canvas, said the famed graffiti artist also known as Rif Raf Giraffe. In 2018, the building now home to King G — a neighborhood bar and deli —…
Fully funded in less than 6 hours: KC-stitched Yardball reinvents the game of catch, nearly doubles Kickstarter goal
Chad Hickman has experienced how easy it is to get lost in a deep conversation while playing a game of catch, he shared. “When your only goal is to throw something back and forth, you can really open up in a conversation and focus on the now. You’re not worried about other things. I used…
Kansas City corporate leader works to take ClimateTech from research to the real world
The solar canopy at Operation Breakthrough’s high-profile STEM lab and youth coworking space was an opportunity for Black & Veatch to put one of the firm’s core capabilities to use for the community and the climate, said Ilya Tabakh. “[Our goal was] to support an initiative that supports STEM education, combines sustainability and technology, and…